Brightsurf Science News & Current Events

December 01, 2018
CAR-T cell update: Therapy improves outcomes for patients with B-cell lymphoma
An international phase-2 trial of a CAR-T cell therapy--to be published on-line Dec.

Studies suggest immunotherapy adds punch to earlier attempts
New drugs that harness the body's immune system to destroy cancer cells appear to increase the effectiveness of later drug therapies for non-Hodgkin and Hodgkin lymphoma patients, new research suggests.

Sickle cell anemia treatment safely lowers disease burden in African children
A daily hydroxyurea pill may bring relief for children living with the painful and deadly blood disease sickle cell anemia (SCA) in resource-challenged sub-Saharan Africa, where the disease is prevalent and health care is suboptimal.

Global trial shows CAR T therapy can lead to durable remissions in non-Hodgkin's lymphoma
In an update to a global clinical trial stretching from Philadelphia to four continents, the chimeric antigen receptor (CAR) T cell therapy Kymriah® (tisagenlecleucel, formerly CTL019) led to long-lasting remissions in patients with relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL).

Snowpack declines may stunt tree growth and forests' ability to store carbon emissions
Researchers conducting a 5-year-long study examining snow cover in a northern hardwood forest region found that projected changes in climate could lead to a 95 percent reduction of deep-insulating snowpack in forest areas across the northeastern United States by the end of the 21st century.

New study highlights CAR T-cell therapy success for lymphoma when used as standard of care
Moffitt Cancer Center partnered with 16 academic cancer centers to analyze real world data of 274 patients treated commercially with Yescarta® (axicabtagene ciloleucel), one of two CAR T products that is now standard of care for patients with diffuse large B cell lymphoma (DLBCL) who have not responded to two or more therapies.

Learning to read comes at a cost
Learning how to read may have some disadvantages for learning grammar.
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.